FDC Ltd
Company Profile
Business description
FDC Ltd is principally engaged in the business of manufacturing and trading pharmaceutical products. It has its presence in numerous therapeutic segments including anti-infectives, gastrointestinal treatments, ophthalmics, vitamins, minerals, dietary supplements, cardiovascular solutions, anti-diabetics, and others. The company's different pharmaceutical products are marketed through brands such as Electral, Enerzal, Zifi, Zocon, Vitcofol, MumMum 1, Victofol Injection, Simyl MCT and many others. Geographically, the company derives maximum revenue from India.
Contact
Off New Link Road
FDC House, C-11 & 12, Dalia Industrial Estate
Oshiwara Village
Andheri - West
MumbaiMH400 053
INDT: +91 2402554407
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
7,076
Stocks News & Analysis
stocks
Do AI labs like Anthropic and OpenAI have economic moats?
stocks
12 picks for an income portfolio - Q3 2026 update
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,937.00 | 59.30 | 0.67% |
| CAC 40 | 7,823.17 | 19.84 | 0.25% |
| DAX 40 | 25,258.98 | 171.71 | 0.68% |
| Dow JONES (US) | 51,884.16 | 229.21 | 0.44% |
| FTSE 100 | 10,641.20 | 89.15 | 0.84% |
| HKSE | 24,271.20 | 59.85 | 0.25% |
| NASDAQ | 27,293.79 | 72.38 | -0.26% |
| Nikkei 225 | 69,030.92 | 11.19 | -0.02% |
| NZX 50 Index | 13,827.62 | 78.27 | 0.57% |
| S&P 500 | 7,810.54 | 1.00 | -0.01% |
| S&P/ASX 200 | 8,783.20 | 66.60 | 0.76% |
| SSE Composite Index | 3,797.24 | 16.55 | -0.43% |